VEGFA and obesity due to melanocortin 4 receptor deficiency: Based on animal studies, administration of VEGF in the early stages of obesity could be beneficial in reducing the tissue-related changes associated with this condition, and could therefore prevent the development of tumors which are associated with obesity.